Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Review of the Global Biotechnology Industry Including for Example the Challenges, Technologies, and the Major Players Involved.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c30833 ) has announced the addition of Global Biotechnology to their offering.

The report provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 understanding of global biotechnology sector. Biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 companies will find the report useful in putting their performance in perspective while end-users such as pharmaceuticals companies will find this report a goldmine A family of front office products for Windows from FrontRange Solutions, Dublin, CA (www.frontrange.com). The product line evolved from the popular GoldMine contact manager, designed for workgroups and providing data synchronization on multiple servers.  of ideas and insights. For companies looking forward to enter biotechnology sector, this report will help in formulating strategy and firming up research priorities. The report is broadly divided into three parts - The first part of the report provides a broad overview of biotechnology through sections such as executive summary, highlights and industry overview. The emphasis is on capturing the essence of the report and presenting it in as succinct suc·cinct  
adj. suc·cinct·er, suc·cinct·est
1. Characterized by clear, precise expression in few words; concise and terse: a succinct reply; a succinct style.

2.
 a manner as possible. The second part of the report analyses specific issues. It is divided into seven sections: Growth drivers, issues and challenges, technologies, major markets, major players, regulatory reg·u·late  
tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates
1. To control or direct according to rule, principle, or law.

2.
 aspects and finally mergers and acquisitions. The gloves are off here. The emphasis is on exhaustive analysis of all facets of biotechnology. The third part of the report pulls together information and analysis from all parts of the report and draws up a road map for the companies and industries. It comprises two sections: Success factors in detail and outlook. While the former isolates critical factors for success in biotechnology, the latter forecasts an outlook for the global biotechnology sector. The report comprises twelve chapters: Executive summary, highlights, industry overview, growth drivers, issues and challenges, technologies, major markets, major players, regulatory aspects, mergers and acquisitions, success factors in detail and outlook. We provide quarterly updates focusing mainly on Industry overview, Major markets , major players, regulations, Mergers and Acquisitions and Future Outlook.

Topics Covered

1. EXECUTIVE SUMMARY

2. HIGHLIGHTS

3. INDUSTRY OVERVIEW

4. GROWTH DRIVERS

5. ISSUES AND CHALLENGES

6. TECHNOLOGY

7. MAJOR MARKETS

8. MAJOR PLAYERS

9. REGULATORY ASPECTS

10. MERGERS & ACQUISITIONS

11. CRITICAL SUCCESS FACTORS

12. FUTURE OUTLOOK

BIBLIOGRAPHY bibliography. The listing of books is of ancient origin. Lists of clay tablets have been found at Nineveh and elsewhere; the library at Alexandria had subject lists of its books.  

Companies Mentioned

--Amgen Inc

--Genentech Inc

--Serono S.A.

--Biogen IDEC IDEC Instituto Brasileiro de Defesa do Consumidor (Portugese: Brazilian Consumer Protection Agency)
IDEC Information Design & End-User Computing
IDEC Interior Design Educators Council, Inc.
 Inc.

--Genzyme Corporation

--Chiron Corporation

--MedImmune, Inc.

--Gilead Sciences, Inc.

--Millennium Pharmaceutical Inc

--InterMune Inc.

--Transgenic seed companies

--Syngenta

--Monsanto

For more information visit http://www.researchandmarkets.com/reports/c30833.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 20, 2006
Words:367
Previous Article:EKWAN-X: Discussions in Progress Regarding Precious Metals Properties in Nevada, USA.
Next Article:Research and Markets: The Volvo Group is One of the Leading Manufacturers of Trucks and Buses.



Related Articles
Let's get personal ... and get involved.
WHAT HAPPENED TO PROFITS?
ALL OF AGRICULTURE MUST SPEAK UP FOR SCIENCE.
A global leader, a personal touch. (2002 Agribusines Leader of the Year).
FMC uses size to its advantage. (View From The Top).
Physician executives as opinion leaders in biotechnology and pharmaceuticals. (Careers: Special Report).
Intellectual property rights in genetics and genomics.
The World of Food Science.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles